Chatbots & Conversational AI for Patient Engagement
With mindsets influenced by on-demand technology, today’s digitally savvy patients want to interact with brands.
So how can pharmaceutical companies do a better job to truly connect with and engage modern patients in their healthcare management experience?
Enter conversational, AI-based intelligent virtual assistants (IVAs) or chatbots.
At the highest level, intelligent virtual assistants optimize communication and engagement between patients and your brand. Smart organizations like Novo Nordisk and UCB are already utilizing the technology as a part of their patient program services to engage and support patients in their healthcare management experience.
They’re also boosting brand loyalty, leveraging data to future-proof strategies and gaining a highly-coveted competitive advantage.
To learn more about what an intelligent virtual assistant can do for your pharmaceutical organization, read our new white paper to find out:
Verint Intelligent Self-Service, a division of Verint, is the team the life science community counts on for intelligent solutions to modern healthcare problems. We unlock the value of human relationships with the power of AI.
We believe technology has a responsibility to deliver value through trusted interactions for both the business and its consumers. Guided by this principle, Verint Intelligent Self-Service has delivered the broadest portfolio of Intelligent Virtual Assistants configured for diabetes, multiple sclerosis, Parkinson’s disease, and women’s health, with several more launching in the coming months. The technology is configured to improve health outcomes, provide access for patients and caregivers to product and health literacy, connect physicians to patient data, and improve the overall experience for patients, healthcare providers, and consumers.